A novel agent with histone deacetylase inhibitory activity attenuates neointimal hyperplasia. [electronic resource]
Producer: 20150605Description: 395-406 p. digitalISSN:- 1573-7241
- Acetylation
- Animals
- Cell Movement -- drug effects
- Cell Proliferation -- drug effects
- Cells, Cultured
- Cyclin-Dependent Kinase Inhibitor p21 -- metabolism
- Cyclin-Dependent Kinase Inhibitor p27 -- metabolism
- Histone Deacetylase Inhibitors -- pharmacology
- Histones -- metabolism
- Humans
- Hydroxamic Acids -- pharmacology
- Hyperplasia -- drug therapy
- Male
- Mice
- Muscle, Smooth, Vascular -- drug effects
- Myocytes, Smooth Muscle -- drug effects
- Neointima -- drug therapy
- Nuclear Receptor Subfamily 4, Group A, Member 1 -- metabolism
- Plasminogen Activator Inhibitor 1 -- metabolism
- Rats
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.